These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 3578846)
1. Effects of U-50488H, a selective kappa-analgesic, on the minimum anesthetic concentration (MAC) of halothane in the rat. Althaus JS; Von Voigtlander PF; DiFazio CA; Miller ED Anesth Analg; 1987 May; 66(5):391-4. PubMed ID: 3578846 [TBL] [Abstract][Full Text] [Related]
2. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid. Vonvoigtlander PF; Lewis RA J Pharmacol Exp Ther; 1988 Jul; 246(1):259-62. PubMed ID: 2839665 [TBL] [Abstract][Full Text] [Related]
3. Biochemical and functional interactions of a selective kappa opioid agonist with calcium. VonVoigtlander PF; Ochoa MC; Lewis RA Adv Exp Med Biol; 1987; 221():345-55. PubMed ID: 2829584 [TBL] [Abstract][Full Text] [Related]
4. Effect of the anticonvulsant U-54494A on cortical neuron excitability: comparison to the kappa agonist U-50488H. Ochoa MC; Vogelsang GD; Lum JT; VonVoigtlander PF; Piercey MF Life Sci; 1992; 50(17):1225-33. PubMed ID: 1349150 [TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant effects of U-54494A and U-50488H in genetically epilepsy-prone rats and DBA/2 mice: a possible involvement of glycine/NMDA receptor complex. De Sarro G; Trimarchi GR; Sinopoli S; Masuda Y; De Sarro A Gen Pharmacol; 1993 Mar; 24(2):439-47. PubMed ID: 8387056 [TBL] [Abstract][Full Text] [Related]
6. Interaction between sufentanil and U-50488H with respect to antinociception and respiratory depression in rats. Verborgh CM; Camu F; Meert TF Acta Anaesthesiol Scand; 1997 Aug; 41(7):895-902. PubMed ID: 9265934 [TBL] [Abstract][Full Text] [Related]
7. Pre- and post-synaptic effects of spiradoline and U-50488H, selective kappa opioid receptor agonists, in isolated ileum. Nomura Y; Hayashi S Scand J Gastroenterol; 1992 Apr; 27(4):295-302. PubMed ID: 1317055 [TBL] [Abstract][Full Text] [Related]
8. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition. Shukla VK; Turndorf H; Bansinath M Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869 [TBL] [Abstract][Full Text] [Related]
9. U-50488H, a selective kappa-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice. Hiramatsu M; Hyodo T; Kameyama T Eur J Pharmacol; 1996 Nov; 315(2):119-25. PubMed ID: 8960874 [TBL] [Abstract][Full Text] [Related]
11. Influence of a mu- and kappa-opioid agonist on isoflurane minimal anesthetic concentration in chickens. Concannon KT; Dodam JR; Hellyer PW Am J Vet Res; 1995 Jun; 56(6):806-11. PubMed ID: 7653892 [TBL] [Abstract][Full Text] [Related]
12. [Comparative studies on the affinities of K-II and U-50488H for kappa opiate receptor]. Li JG; Ma SC; Lu SN; Wang CQ Yao Xue Xue Bao; 1991; 26(1):10-4. PubMed ID: 1653514 [TBL] [Abstract][Full Text] [Related]
13. Reduction in halothane MAC: comparison of morphine and alfentanil. Lake CL; DiFazio CA; Moscicki JC; Engle JS Anesth Analg; 1985 Aug; 64(8):807-10. PubMed ID: 3925818 [TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury. Hall ED; Wolf DL; Althaus JS; Von Voigtlander PF Brain Res; 1987 Dec; 435(1-2):174-80. PubMed ID: 2827851 [TBL] [Abstract][Full Text] [Related]
15. The kappa opioid-related anticonvulsants U-50488H and U-54494A attenuate N-methyl-D-aspartate induced brain injury in the neonatal rat. Hudson CJ; Von Voigtlander PF; Althaus JS; Scherch HM; Means ED Brain Res; 1991 Nov; 564(2):261-7. PubMed ID: 1725768 [TBL] [Abstract][Full Text] [Related]
16. Interaction between halothane and mu, delta and kappa opioid agonists on the isolated right atria of the rat. Micol JA; Laorden ML Br J Anaesth; 1992 Nov; 69(5):487-91. PubMed ID: 1334686 [TBL] [Abstract][Full Text] [Related]
18. U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse. Piercey MF; Lahti RA; Schroeder LA; Einspahr FJ; Barsuhn C Life Sci; 1982 Sep 20-27; 31(12-13):1197-200. PubMed ID: 6292608 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of the expression of ornithine decarboxylase by some kappa-opioidergic receptor ligands in difluoromethylornithine-resistant L1210 cells. Flamigni F; Stefanelli C; Stanic I; Muscari C; Giaccari A; Rossoni C Biochim Biophys Acta; 1996 May; 1311(3):204-10. PubMed ID: 8664348 [TBL] [Abstract][Full Text] [Related]
20. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration. Parsons CG; West DC; Headley PM Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]